News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,959 Results
Type
Article (61196)
Company Profile (173)
Press Release (623590)
Section
Business (187220)
Career Advice (2854)
Deals (34969)
Drug Delivery (93)
Drug Development (79756)
Employer Resources (163)
FDA (16118)
Job Trends (15280)
News (327619)
Policy (33099)
Tag
Academia (2840)
Africa (970)
Alliances (46759)
Alzheimer's disease (1178)
Approvals (16049)
Arizona (142)
Artificial intelligence (90)
Asia (39777)
Australia (7033)
Bankruptcy (324)
Best Places to Work (11796)
Biosimilars (70)
Biotechnology (111)
Breast cancer (75)
C2C Services and Suppliers (75143)
California (1966)
Canada (988)
Cancer (594)
Career advice (2411)
Cell therapy (157)
China (156)
Clinical research (62538)
Collaboration (190)
Colorado (87)
Connecticut (91)
COVID-19 (2654)
Cystic fibrosis (80)
Data (471)
Diabetes (99)
Diagnostics (6274)
Drug pricing (87)
Earnings (65179)
Employer resources (142)
Europe (91725)
Events (108562)
Executive appointments (194)
FDA (16426)
Florida (295)
Funding (177)
Gene therapy (100)
Georgia (78)
GLP-1 (549)
Government (4874)
Healthcare (19878)
Hotbed/Location (453032)
Illinois (302)
Indiana (165)
Infectious disease (2693)
Inflammatory bowel disease (96)
Interviews (537)
IPO (15841)
Job creations (3690)
Job search strategy (2040)
Kansas (97)
Layoffs (449)
Legal (7523)
Lung cancer (116)
Manufacturing (109)
Maryland (426)
Massachusetts (1587)
Medical device (13566)
Medtech (13571)
Mergers & acquisitions (19061)
Metabolic disorders (288)
Michigan (137)
Minnesota (211)
Neuroscience (1362)
New Jersey (636)
New York (637)
NextGen Class of 2024 (7013)
Non-profit (4862)
North Carolina (646)
Northern California (878)
Obesity (177)
Ohio (114)
Opinion (208)
Patents (77)
Pennsylvania (583)
People (59391)
Phase I (19474)
Phase II (27387)
Phase III (20454)
Pipeline (131)
Policy (69)
Postmarket research (2677)
Preclinical (8197)
Radiopharmaceuticals (246)
Rare diseases (159)
Real estate (6157)
Regulatory (21775)
Research institute (2517)
Resumes & cover letters (438)
South America (1291)
Southern California (805)
Startups (3551)
Texas (269)
United States (9110)
Vaccines (542)
Washington State (264)
Weight loss (146)
Date
Today (193)
Last 7 days (707)
Last 30 days (2828)
Last 365 days (36466)
2024 (26996)
2023 (39676)
2022 (50769)
2021 (55880)
2020 (55095)
2019 (48999)
2018 (37218)
2017 (33040)
2016 (32889)
2015 (38456)
2014 (31369)
2013 (27264)
2012 (28754)
2011 (29089)
2010 (27465)
684,959 Results for "harvard school of public health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research
Healis Therapeutics is pleased to announce that it has entered a clinical collaboration with Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, and affiliates of Harvard Medical School (HMS).
March 26, 2024
·
1 min read
Business
Inflammatory Bowel Disease Expert and Harvard Medical School Faculty Dr. Hamed Khalili Joins Vivante Health’s Clinical Advisory Board
Vivante Health, the employee benefit for GI care, announced the addition of Dr. Hamed Khalili to its Clinical Advisory Board.
February 26, 2024
·
2 min read
Genetown
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
May 23, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
May 16, 2024
·
1 min read
Deals
Fractyl Health Announces Pricing of Initial Public Offering
Fractyl Health announced the pricing of its initial public offering of 7,333,333 shares of common stock at a public offering price of $15.00 per share, for total gross proceeds of approximately $110.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Fractyl Health.
February 1, 2024
·
3 min read
Press Releases
Tevogen Bio’s Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund, Appointed Dean of the University of South Florida Health College of Public Health
August 14, 2024
·
2 min read
BioCapital
The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment
The Foundation for the National Institutes of Health announces the launch of a public-private partnership to build the largest data source for amyotrophic lateral sclerosis and expedite the identification of biomarkers and clinical outcome assessments that would allow earlier diagnosis and accelerated drug development for people living with the disease.
May 21, 2024
·
6 min read
Business
Kaiser Permanente Bernard J. Tyson School of Medicine appoints Dr. John L. Dalrymple as new Dean and CEO
The Board of Directors of the Kaiser Permanente Bernard J. Tyson School of Medicine announced the appointment of physician, educator, and women’s health expert John L. Dalrymple, MD, as the school’s new Dean and CEO after an extensive national search.
April 16, 2024
·
4 min read
Lone Star Bio
Nexalin Technology Announces Pricing of $5.2 Million Public Offering
Nexalin Technology, Inc. announced the pricing of a public offering of 3,000,000 shares of common stock at public offering price of $1.75.
June 27, 2024
·
3 min read
Deals
BrightSpring Health Services Announces Pricing of its Initial Public Offering and Concurrent Offering of Tangible Equity Units
BrightSpring Health Services, Inc. (“BrightSpring” or “BrightSpring Health Services”) today announced the pricing of an initial public offering of 53,333,334 shares of its common stock at $13.00 per share and a concurrent offering of 8,000,000 of its 6.75% tangible equity units (“Units”), with a stated amount of $50.00 per Unit.
January 25, 2024
·
5 min read
1 of 68,496
Next